View in EDS

MND1 reduces breast cancer chemosensitivity by promoting RAD51-mediated homologous recombination repair.

Saved in:
Bibliographic Details
Title: MND1 reduces breast cancer chemosensitivity by promoting RAD51-mediated homologous recombination repair.
Authors: Yue HR; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China., Yu ZH; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China., Zhao HM; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China., Hai LY; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China., Liu WB; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China., Liu XF; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China., Chen ZH; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China., Yu Y; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. yuyue@tmu.edu.cn.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. yuyue@tmu.edu.cn.; Tianjin's Clinical Research Center for Cancer, Tianjin, China. yuyue@tmu.edu.cn.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China. yuyue@tmu.edu.cn., Ge J; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. gejie1980@tmu.edu.cn.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. gejie1980@tmu.edu.cn.; Tianjin's Clinical Research Center for Cancer, Tianjin, China. gejie1980@tmu.edu.cn.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China. gejie1980@tmu.edu.cn., Wang X; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. wangxin@tjmuch.com.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. wangxin@tjmuch.com.; Tianjin's Clinical Research Center for Cancer, Tianjin, China. wangxin@tjmuch.com.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China. wangxin@tjmuch.com.
Source: Cell death & disease [Cell Death Dis] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42236675
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MND1 reduces breast cancer chemosensitivity by promoting RAD51-mediated homologous recombination repair.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yue+HR%22">Yue HR</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Yu+ZH%22">Yu ZH</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhao+HM%22">Zhao HM</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Hai+LY%22">Hai LY</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Liu+WB%22">Liu WB</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Liu+XF%22">Liu XF</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Chen+ZH%22">Chen ZH</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Yu+Y%22">Yu Y</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. yuyue@tmu.edu.cn.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. yuyue@tmu.edu.cn.; Tianjin's Clinical Research Center for Cancer, Tianjin, China. yuyue@tmu.edu.cn.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China. yuyue@tmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Ge+J%22">Ge J</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. gejie1980@tmu.edu.cn.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. gejie1980@tmu.edu.cn.; Tianjin's Clinical Research Center for Cancer, Tianjin, China. gejie1980@tmu.edu.cn.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China. gejie1980@tmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. wangxin@tjmuch.com.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. wangxin@tjmuch.com.; Tianjin's Clinical Research Center for Cancer, Tianjin, China. wangxin@tjmuch.com.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, China. wangxin@tjmuch.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2026 Jun 03. <i>Date of Electronic Publication: </i>2026 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42236675
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-026-08912-w
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: MND1 reduces breast cancer chemosensitivity by promoting RAD51-mediated homologous recombination repair.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yue HR
      – PersonEntity:
          Name:
            NameFull: Yu ZH
      – PersonEntity:
          Name:
            NameFull: Zhao HM
      – PersonEntity:
          Name:
            NameFull: Hai LY
      – PersonEntity:
          Name:
            NameFull: Liu WB
      – PersonEntity:
          Name:
            NameFull: Liu XF
      – PersonEntity:
          Name:
            NameFull: Chen ZH
      – PersonEntity:
          Name:
            NameFull: Yu Y
      – PersonEntity:
          Name:
            NameFull: Ge J
      – PersonEntity:
          Name:
            NameFull: Wang X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 06
              Text: 2026 Jun 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1